The Trump administration is proposing to scrap a dozen quality measures for Medicare Advantage plans and not move forward with a Biden administration plan to reward insurers that improve the health of low-income and disabled enrollees.

In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a multi-billion-dollar government